Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q2 2026 ▲▼ | Q3 2026 ▲▼ | Change ▲▼ | Q2 2026 ▲▼ | Q3 2026 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Spyre Therapeutics, Inc.(SYRE) | 0 | 1,160,620 | +1,160,620 | $0 | $103.33M | 37.77% | +$103.33M |
| Oruka Therapeutics, Inc.(ORKA) | 0 | 954,150 | +954,150 | $0 | $79.47M | 29.05% | +$79.47M |
| Damora Therapeutics, Inc.(DMRA) | 0 | 2,045,473 | +2,045,473 | $0 | $43.53M | 15.91% | +$43.53M |
| Jade Biosciences Inc | 0 | 1,807,814 | +1,807,814 | $0 | $25.40M | 9.28% | +$25.40M |
| Korsana Biosciences Inc | 0 | 518,500 | +518,500 | $0 | $16.59M | 6.06% | +$16.59M |
| Crescent Biopharma Inc | 0 | 361,250 | +361,250 | $0 | $5.27M | 1.93% | +$5.27M |